Condensed Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Revenue:
Total revenues	$ 30,761	$ 0
Cost and operating expenses:
Cost of product revenue	2,884	0
Research and development	39,619	40,210
Selling, general and administrative	29,325	26,557
Total cost and operating expenses	71,828	66,767
Loss from operations	(41,067)	(66,767)
Non-operating income:
Investment income, net	5,094	4,365
Other income (expense), net	(23)	(10)
Total non-operating income, net	5,071	4,355
Loss before income taxes	(35,996)	(62,412)
Income tax benefit (expense)	0	0
Net income (loss)	$ (35,996)	$ (62,412)
Net income (loss) per share - basic	$ (0.35)	$ (0.72)
Net income (loss) per share - diluted	$ (0.35)	$ (0.72)
Weighted-average number of common shares used in net income (loss) per share - basic	102,710,382	86,679,282
Weighted-average number of common shares used in net income (loss) per share - diluted	102,710,382	86,679,282
Product revenue, net [Member]
Revenue:
Total revenues	$ 30,503	$ 0
License revenue [Member]
Revenue:
Total revenues	$ 258	$ 0